SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert DeHaven who wrote (274)3/8/1998 11:46:00 AM
From: Manny Gugliuzza   of 1510
 
speaking of looking forward to those mountains to climb**********

just got a look at earnings estimate for 1999 and seems we have finally entered into the positive. i have no idea where they drew this number from the expected sales of remune.

at .50cents/share with an average multiple of 28.5 for the industry.
14.25

any fundamentalist think this is low, high or right on please speak up
now so maybe we can take out those recent highs with anticipation.

although this seems far off now to us markets in these stocks do trade ahead of this how far i have no ideas either.

i hope this estimate is conservative even though the approval from fda will obviously be with the combo therapy first after completion of phase II with no phase III needed this year, and especially after phase III completion in 1 year when it can be use alone for therapy.

although we had a little gap up in trading i am convinced that the piercing and closure below the majority of bollinger trading day scenarios has put in the bottom. hopefully looking to leave these single digits far behind us and for a long long time, good luck to
those still with it.

ar.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext